Diversigen and CoreBiome have come together to create one company that is powering microbiome discovery through sequencing, analysis, and consulting services geared toward the study of the microbiome of living organisms and environments. The combined bench strength of the merged organization is unparalleled in the industry, providing you with access to those who are pioneering advancements in the microbiome field.  

By working closely with key manufacturers and applying laboratory best practices, Diversigen has developed state-of-the-art techniques to extract high quality nucleic acids from a variety of sample types for subsequent metagenomic analysis.

Our flexible sequencing and computing capacity, combined with ongoing improvement of analytic tools and their applications, allow us to customize unique strategies on a per-project basis.

Diversigen takes pride in one-on-one consultation with the customer until complete satisfaction is achieved. The services we offer cover the full spectrum from organism detection, to analysis, and consultation. We believe in transparency through the pipeline process and provide customers with access to the best science in the microbiome field and the responsive service you have come to expect.

Where we came from


Diversigen is a microbiome industry pioneer. The company was founded in 2013 by Dr. Joseph Petrosino, director of the Alkek Center for Metagenomics and Microbiome Research at the Baylor College of Medicine (BCM), where Diversigen is a BCM portfolio company.

As the first company to establish microbiome protocols in accordance with College of American Pathologists (CAP) accreditation and Clinical Laboratory Improvements Amendments of 1988 (CLIA) guidelines, Diversigen has a strong track record of supporting microbiome-focused clinical trials for big pharma customers, as well as thought-leading microbiome-focused biotech companies.

In November 2019, Diversigen became a wholly-owned subsidiary of OraSure, Inc., headquartered in Bethlehem, Pennsylvania.


CoreBiome was a microbiome sequencing and analysis provider run by microbiome scientists. Founders, Dan Knights (CEO), Daryl Gohl (CSO), and Kenny Beckman (COO), are experts in the fields of microbiome science and high-throughput genomics.

CoreBiome was built on intellectual property licensed from the founders’ labs in Computer Science, the BioTechnology Institute, and the Genomics Center at the University of Minnesota.

CoreBiome is a licensee of University of Minnesota (UMN) intellectual property; and was originally incorporated in July of 2016, as Micrometer, Inc. CoreBiome received seed funding from angel investors and the UMN’s investment fund (Discovery Capital).

In January 2019, CoreBiome became a wholly-owned subsidiary of OraSure, Inc., headquartered in Bethlehem, Pennsylvania.

Diversigen provides services and generates data for research purposes only.  Not all services are available in all regions.